Advertisement
Journal Home
Search for

Volume 81, Issue 4, Pages 299-303 (April 2010)


View previous. 8 of 19 View next.

Correlates of use of long-acting reversible methods of contraception among adolescent and young adult women

Amy K. WhitakerCorresponding Author Informationemail address, Annie M. Dude, Amy Neustadt, Melissa L. Gilliam

Received 13 August 2009; received in revised form 16 November 2009; accepted 20 November 2009. published online 01 February 2010.

Abstract 

Background

Most pregnancies among adolescent and young adult women are unintended, and adolescent birth rates have risen. Use of long-acting reversible contraception may be an effective strategy to reduce the rate of unintended pregnancy.

Study Design

We conducted a secondary data analysis of nationally representative, cross-sectional data from the 2002 National Survey of Family Growth. Our sample included 1722 sexually active women aged 15–24 years. We used multivariable logistic regression to identify correlates of ever-use of depot-medroxyprogesterone acetate (DMPA) or the intrauterine device (IUD).

Results

One-quarter of our sample had ever used DMPA, and less than 2% had ever used the IUD. In multivariable analysis, increasing parity was associated with ever-use of DMPA (OR 2.07, 95% CI 1.55–2.77) and ever-use of the IUD (OR 4.57, 95% CI 1.60–13.03), but age and measures of socioeconomic status were not. Having ever been married (OR 5.54, 95% CI 1.23–24.82) and current cohabitation (OR 4.89, 95% CI 1.10–21.71) were associated with ever-use of the IUD. A history of an adolescent pregnancy was associated with ever-use of DMPA (OR 1.79, 95% CI 1.19–2.70) but not of the IUD.

Conclusions

While similarities exist between the correlates of use of DMPA and the IUD, we discovered important differences, some of which may reflect provider biases regarding IUD provision.

Department of Obstetrics and Gynecology, University of Chicago Medical Center, Chicago, IL 60637, USA

Corresponding Author InformationCorresponding author. Tel.: +1 773 834 4129; fax: +1 773 702 0840.

 The study was funded by an anonymous foundation.

PII: S0010-7824(09)00517-4

doi:10.1016/j.contraception.2009.11.008


View previous. 8 of 19 View next.

Advertisement